Diagnostic markers in neonatal sepsis

Fetal and Maternal Medicine Review

Volumn 18, Issue 1, 2007, Pages 53-65

  Lam, Hugh S ^a   Ng, Pak C ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA CHEMOKINE; BIOLOGICAL MARKER; C REACTIVE PROTEIN; CD11B ANTIGEN; CD18 ANTIGEN; CD45RA ANTIGEN; CD45RO ANTIGEN; CD64 ANTIGEN; CD69 ANTIGEN; CELL SURFACE MARKER; CHEMOKINE; CYTOKINE; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GRANULOCYTE COLONY STIMULATING FACTOR; HLA DR ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 8; LIPOPOLYSACCHARIDE BINDING PROTEIN; MONOCYTE CHEMOTACTIC PROTEIN 1; PROCALCITONIN; RANTES; SERINE PROTEINASE INHIBITOR; SERUM AMYLOID A; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; UNINDEXED DRUG;

APOPTOSIS; BACTERIUM CULTURE; BLOOD ANALYSIS; COAGULASE NEGATIVE STAPHYLOCOCCUS; EARLY DIAGNOSIS; FLUORESCENCE IN SITU HYBRIDIZATION; HEMATOLOGY; HOSPITALIZATION; HUMAN; LENGTH OF STAY; LEUKOCYTOSIS; LYMPHOCYTE; MONOCYTE; NATURAL KILLER CELL; NEONATOLOGY; NEUTROPHIL; NEWBORN MORTALITY; NEWBORN SEPSIS; PROGNOSIS; REVIEW; RNA PROBE; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; T LYMPHOCYTE; UMBILICAL CORD BLOOD; VERY LOW BIRTH WEIGHT;

EID: 34247606374     PISSN: 09655395     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0965539507001866     Document Type: Review

References (62)

1. Philip AG. The evolution of neonatology. Pediatr Res 2005; 58: 799-815.
2. Bland RD. Neonatal chronic lung disease in the post-surfactant era. Biol Neonate 2005; 88: 181-91.
3. Ng PC, Wong HL, Lyon DJ, So KW, Liu F, Lam RK et al. Combined use of alcohol hand rub and gloves reduces the incidence of late onset infection in very low birthweight infants. Arch Dis Child Fetal Neonatal Ed 2004; 89: F336-40.
4. Stoll BJ, Hansen N. Infections in VLBW infants: studies from the NICHDNeonatal Research Network. Semin Perinatol 2003; 27: 293-301.
5. Stoll BJ, Hansen N, Fanaroff AA, Wright LL, Carlo WA, Ehrenkranz RA et al. Late-onset sepsis in very low birth weight neonates: the experience of the NICHD Neonatal Research Network. Pediatrics 2002; 110: 285-91.
6. Stoll BJ, Gordon T, Korones SB, Shankaran S, Tysen JE, Bauer CR et al. Early-onset sepsis in very low birth weight neonates: a report from the National Institute of Child Health and Human Development Neonatal Research Network. J Pediatr 1996; 129: 72-80.
7. Stoll BJ, Gordon T, Korones SB, Shankaran S, Tysen JE, Bauer CR et al. Late-onset sepsis in very low birth weight neonates: a report from the National Institute of Child Health and Human Development Neonatal Research Network. J Pediatr 1996; 129: 63-71.
8. Stoll BJ, Hansen NI, Adams-Chapman I, Fanaroff AA, Hintz SR, Vohr B et al. Neurodevelopmental and growth impairment among extremely low-birth-weight infants with neonatal infection. JAMA 2004; 292: 2357-65.
9. Ng PC. Diagnostic markers of infection in neonates. Arch Dis Child Fetal Neonatal Ed 2004; 89: F229-35.
10. Stoll BJ, Hansen N, Fanaroff AA, Wright LL, Carlo WA, Ehrenkranz RA et al. Changes in pathogens causing early-onset sepsis in very-low-birth- weight infants. N Engl J Med 2002; 347: 240-47.
11. Polin RA. The "ins and outs" of neonatal sepsis. J Pediatr 2003; 143: 3-4.
12. Ng PC. Clinical trials for evaluating diagnostic markers of infection in neonates. Biol Neonate 2005; 87: 111-2.
13. Lekkou A, Karakantza M, Mouzaki A, Kalfarentzos F, Gogos CA. Cytokine production and monocyte HLA-DR expression as predictors of outcome for patients with community-acquired severe infections. Clin Diagn Lab Immunol 2004; 11: 161-67.
14. Zakynthinos SG, Papanikolaou S, Theodoridis T, Zakynthinos EG, Christopoulou-Kokkinou V, Katsaris G et al. Sepsis severity is the major determinant of circulating thrombopoietin levels in septic patients. Crit Care Med 2004; 32: 1004-10.
15. Arnon S, Litmanovitz I, Regev R, Lis M, Shainkin-Kestenbaum R, Dolfin T. The prognostic virtue of inflammatory markers during late-onset sepsis in preterm infants. J Perinat Med 2004; 32: 176-80.
16. Ng PC, Cheng SH, Chui KM, Fok TF, Wong MY, Wong W et al. Diagnosis of late onset neonatal sepsis with cytokines, adhesion molecule, and C-reactive protein in preterm very low birthweight infants. Arch Dis Child Fetal Neonatal Ed 1997; 77: F221-27.
17. Ng PC, Li K, Wong RP, Chui K, Wong E, Li G et al. Proinflammatory and anti-inflammatory cytokine responses in preterm infants with systemic infections. Arch Dis Child Fetal Neonatal Ed 2003; 88: F209-13.
18. Schultz C, Temming P, Bucsky P, Gopel W, Strunk T, Hartel C. Immature anti-inflammatory response in neonates. Clin Exp Immunol 2004; 135: 130-36.
19. Hodge G, Hodge S, Haslam R, McPhee A, Sepulveda H, Morgan E et al. Rapid simultaneous measurement of multiple cytokines using 100 microl sample volumes-association with neonatal sepsis. Clin Exp Immunol 2004; 137: 402-407.
20. Procianoy RS, Silveira RC. The role of sample collection timing on interleukin-6 levels in early-onset neonatal sepsis. J Pediatr 2004; 80: 407-10.
21. Verboon-Maciolek MA, Thijsen SF, Hemels MA, Menses M, van Loon AM, Krediet TG et al. Inflammatory mediators for the diagnosis and treatment of sepsis in early infancy. Pediatr Res 2006; 59: 457-61.
22. D'Alquen D, Kramer BW, Seidenspinner S, Marx A, Berg D, Groneck P et al. Activation of umbilical cord endothelial cells and fetal inflammatory response in preterm infants with chorioamnionitis and funisitis. Pediatr Res 2005; 57: 263-69.
23. Franz AR, Bauer K, Schalk A, Garland SM, Bowman ED, Rex K et al. Measurement of interleukin 8 in combination with C-reactive protein reduced unnecessary antibiotic therapy in newborn infants: a multicenter, randomized, controlled trial. Pediatrics 2004; 114: 1-8.
24. Horisberger T, Harbarth S, Nadal D, Baenziger O, Fischer JE. G-CSF and IL-8 for early diagnosis of sepsis in neonates and critically ill children - safety and cost effectiveness of a new laboratory prediction model: study protocol of a randomized controlled trial. Crit Care 2004; 8: R443-50.
25. Orlikowsky TW, Neunhoeffer F, Goelz R, Eichner M, Henkel C, Zwirner M et al. Evaluation of IL-8-concentrations in plasma and lysed EDTA-blood in healthy neonates and those with suspected early onset bacterial infection. Pediatr Res 2004; 56: 804-809.
26. van Dissel JT, van Langevelde P, Westendorp RG, Kwappenberg K, Frolich M. Anti-inflammatory cytokine profile and mortality in febrile patients. Lancet 1998; 351: 950-53.
27. Ng PC, Li K, Leung TF, Wong RP, Li G, Chui KM et al. Early prediction of sepsis-induced disseminated intravascular coagulation with interleukin-10, interleukin-6, and RANTES in preterm infants. Clin Chem 2006; 52: 1181-189.
28. Ng PC, Li K, Chui KM et al. IP-10 is an Early Diagnostic Marker for Identification of Late-Onset Bacterial Infection in Preterm Infants. Pediatr Res 2007 (in press).
29. Ng PC, Li G, Chui KM, Chu WC, Li K, Wong RP et al. Neutrophil CD64 is a sensitive diagnostic marker for early-onset neonatal infection. Pediatr Res 2004; 56: 796-803.
30. Ng PC, Li K, Wong RP, Chui KM, Wong E, Fok TF. Neutrophil CD64 expression: a sensitive diagnostic marker for late-onset nosocomial infection in very low birthweight infants. Pediatr Res 2002; 51: 296-303.
31. Hodge G, Hodge S, Han P, Haslam R. Multiple leucocyte activation markers to detect neonatal infection. Clin Exp Immunol 2004; 135: 125-29.
32. Turunen R, Andersson S, Nupponen I, Kautiainen H, Siitonen S, Repo H. Increased CD11b-density on circulating phagocytes as an early sign of late-onset sepsis in extremely low-birth-weight infants. Pediatr Res 2005; 57: 270-75.
33. Nupponen I, Andersson S, Jarvenpaa AL, Kautiainen H, Repo H. Neutrophil CD11b expression and circulating interleukin-8 as diagnostic markers for early-onset neonatal sepsis. Pediatrics 2001; 108: E12.
34. Weinschenk NP, Farina A, Bianchi DW. Premature infants respond to early-onset and late-onset sepsis with leukocyte activation. J Pediatr 2000; 137: 345-50.
35. Nupponen I, Pesonen E, Andersson S, Makela A, Turunen R, Kautiainen H et al. Neutrophil activation in preterm infants who have respiratory distress syndrome. Pediatrics 2002; 110: 36-41.
36. Hallwirth U, Pomberger G, Zaknun D, Szepfalusi Z, Horcher E, Pollak A et al. Monocyte phagocytosis as a reliable parameter for predicting early-onset sepsis in very low birthweight infants. Early Hum Dev 2002; 67: 1-9.
37. Ng PC, Li G, Chui KM, Chu WC, Li K, Wong RP et al. Quantitative Measurement of Monocyte HLA-DR Expression in the Identification of Early-Onset Neonatal Infection. Biol Neonate 2005; 89: 75-81.
38. Hodge S, Hodge G, Flower R, Han P. Surface activationmarkers of T lymphocytes: role in the detection of infection in neonates. Clin Exp Immunol 1998; 113: 33-38.
39. Hodge G, Hodge S, Markus C, Lawrence A, Han P. A marked decrease in L-selectin expression by leucocytes in infants with Bordetella pertussis infection: leucocytosis explained? Respirology 2003; 8: 157-62.
40. Resch B, Gusenleitner W, Muller WD. Procalcitonin and interleukin-6 in the diagnosis of early-onset sepsis of the neonate. Acta Paediatr 2003; 92: 243-45.
41. Pavcnik-Arnol M, Hojker S, Derganc M. Lipopolysaccharide-binding protein in critically ill neonates and children with suspected infection: comparison with procalcitonin, interleukin-6, and C-reactive protein. Intensive Care Med 2004; 30: 1454-460.
42. van Rossum AM, Wulkan RW, Oudesluys-Murphy AM. Procalcitonin as an early marker of infection in neonates and children. Lancet Infect Dis 2004; 4: 620-30.
43. Thayyil S, Shenoy M, Hamaluba M, Gupta A, Frater J, Verber IG. Is procalcitonin useful in early diagnosis of serious bacterial infections in children? Acta Paediatr 2005; 94: 155-58.
44. Arnon S, Litmanovitz I, Regev R, Bauer S, Lis M, Shainkin-Kestenbaum R et al. Serum amyloid A protein is a useful inflammatory marker during late-onset sepsis in preterm infants. Biol Neonate 2005; 87: 105-10.
45. Lannergard A, Friman G, Ewald U, Lind L, Larsson A. Serum amyloid A (SAA) protein and high-sensitivity C-reactive protein (hsCRP) in healthy newborn infants and healthy young through elderly adults. Acta Paediatr 2005; 94: 1198-202.
46. Behrendt D, Dembinski J, Heep A, Bartmann P. Lipopolysaccharide binding protein in preterm infants. Arch Dis Child Fetal Neonatal Ed 2004; 89: F551-54.
47. Fries E, Kaczmarczyk A. Inter-alpha-inhibitor, hyaluronan and inflammation. Acta Biochim Pol 2003; 50: 735-42.
48. Lim YP, Bendelja K, Opal SM, Siryaporn E, Hixson DC, Palardy JE. Correlation between mortality and the levels of inter-alpha inhibitors in the plasma of patients with severe sepsis. J Infect Dis 2003; 188: 919-26.
49. Baek YW, Brokat S, Padbury JF, Pinar H, Hixson DC, Lim YP. Inter-alpha inhibitor proteins in infants and decreased levels in neonatal sepsis. J Pediatr 2003; 143: 11-5.
50. Turner D, Hammerman C, Rudensky B, Schlesinger Y, Goia C, Schimmel MS. Procalcitonin in preterm infants during the first few days of life: introducing an age related nomogram. Arch Dis Child Fetal Neonatal Ed 2006; 91: F283-86.
51. Resch B, Gusenleitner W, Muller W. Procalcitonin, interleukin-6, C-reactive protein and leukocyte counts in infants with bronchiolitis. Pediatr Infect Dis J 2003; 22: 475-76.
52. Joram N, Boscher C, Denizot S, Loubersac V, Winer N, Roze JC et al. Umbilical cord blood procalcitonin and C reactive protein concentrations as markers for early diagnosis of very early onset neonatal infection. Arch Dis Child Fetal Neonatal Ed 2006; 91: F65-66.
53. Peters RP, Savelkoul PH, Simoons-Smit AM, Danner SA, Vandenbroucke-Grauls CM, van Agtmael MA. Faster identification of pathogens in positive blood cultures by fluorescence in situ hybridization in routine practice. J Clin Microbiol 2006; 44: 119-23.
54. Marlowe EM, Hogan JJ, Hindler JF, Andruszkiewicz I, Gordon P, Bruckner DA. Application of an rRNA probe matrix for rapid identification of bacteria and fungi from routine blood cultures. J Clin Microbiol 2003; 41: 5127-133.
55. Saglani S, Harris KA, Wallis C, Hartley JC. Empyema: the use of broad range 16S rDNA PCR for pathogen detection. Arch Dis Child 2005; 90: 70-73.
56. Breitkopf C, Hammel D, Scheld HH, Peters G, Becker K. Impact of a molecular approach to improve the microbiological diagnosis of infective heart valve endocarditis. Circulation 2005; 111: 1415-421.
57. Call DR, Bakko MK, Krug MJ, Roberts MC. Identifying antimicrobial resistance genes with DNA microarrays. Antimicrob Agents Chemother 2003; 47: 3290-295.
58. Perreten V, Vorlet-Fawer L, Slickers P, Ehricht R, Kuhnert P, Frey J. Microarray-based detection of 90 antibiotic resistance genes of gram-positive bacteria. J Clin Microbiol 2005; 43: 2291-302.
59. Rantakokko-Jalava K, Jalava J. Optimal DNA isolation method for detection of bacteria in clinical specimens by broad-range PCR. J Clin Microbiol 2002; 40: 4211-217.
60. Wittenhagen P, Kronborg G, Weis N, Nielsen H, Obel N, Pedersen SS et al. The plasma level of soluble urokinase receptor is elevated in patients with Streptococcus pneumoniae bacteraemia and predicts mortality. Clin Microbiol Infect 2004; 10: 409-15.
61. Ward PA. The dark side of C5a in sepsis. Nat Rev Immunol 2004; 4: 133-42.
62. Huber-Lang M, Sarma JV, Rittirsch D, Schreiber H, Weiss M, Flierl M et al. Changes in the novel orphan, C5a receptor (C5L2), during experimental sepsis and sepsis in humans. J Immunol 2005; 174: 1104-10.